How AI Is Being Used in Medicine, Law, and Finance (And What It Means for Evaluators)
AI deployment in professional services is moving faster than most people outside those industries realise. The products being built and sold today are not demonstrations or prototypes. They are clinical documentation tools used in hospitals, contract review systems deployed at law firms, and financial analysis platforms integrated into investment workflows.
Each of these applications needs human expertise to train, evaluate, and continuously improve it. Understanding where AI is actually being deployed in each domain, what capabilities it is being built for, and where it tends to fail is directly useful for anyone thinking about specialist AI evaluation as a professional path.
AI in medicine
What is being built
Clinical documentation is the largest current application. AI systems that listen to patient-clinician conversations and generate structured clinical notes have moved from pilot to mainstream deployment at healthcare providers in the UK and US. The manual documentation burden on clinicians is significant, and automation of that burden has clear value.
Diagnostic support tools are a growing category. AI systems that assist radiologists in reading imaging studies, flag abnormal pathology in histopathology slides, or highlight potential drug interactions in a patient's medication list are deployed in clinical settings, typically as decision support rather than autonomous decision-making.
Clinical literature summarisation is an active development area. AI tools that help clinicians stay current with relevant research, generate evidence summaries for specific clinical questions, or assist with clinical guideline development are being built and evaluated by major healthcare institutions.
Patient-facing AI is expanding. Triage chatbots, symptom checkers, and patient education tools are increasingly AI-powered. The safety requirements for patient-facing AI are particularly stringent because the user population is broad, often vulnerable, and may act directly on what the AI says.
Where AI fails in clinical contexts
The failure modes that matter most in clinical AI are not random errors. They cluster around specific vulnerability types:
Confident misstatement of clinical facts is the most dangerous failure. An AI that describes a contraindication incorrectly, misstates a drug dosage, or describes a disease mechanism inaccurately in fluent, authoritative language is a safety risk specifically because the error is invisible to non-specialists.
Inappropriate certainty about genuinely uncertain clinical questions. Clinical medicine contains a great deal of legitimate uncertainty. AI systems trained without careful attention to uncertainty expression can present contested clinical evidence as settled, or omit the caveat that guidelines vary by patient population.
Failure to flag when AI assistance is insufficient. A patient asking an AI tool about a symptom pattern that requires immediate clinical assessment needs the AI to recognise that and direct them appropriately, not provide a reassuring general explanation.
What clinical AI evaluators do
Clinical AI evaluators assess whether outputs are medically accurate, appropriately caveated, and safe for the stated context. This requires reading AI responses the way a clinician would: actively checking specific claims against known clinical evidence, assessing whether the level of certainty expressed is appropriate, and considering whether the response would be safe if acted on by the user it is directed at.
The clinical credentials required vary by application. Evaluating a clinical documentation AI for a general medicine context requires different knowledge than evaluating a specialist oncology AI or a psychiatric AI.
AI in law
What is being built
Contract review and analysis is the most mature legal AI application. Systems that identify and extract key provisions from commercial contracts, flag missing or unusual clauses, compare contract terms against standard templates, and summarise contractual obligations are widely deployed at law firms and in-house legal departments.
Legal research assistance is a major development area. AI tools that assist with case law research, statutory interpretation, and regulatory compliance monitoring are being integrated into legal practice management systems.
Document drafting assistance is growing. AI systems that draft or redline contracts, generate legal correspondence, or assist with document production in litigation contexts are deployed at various stages of the drafting workflow.
Regulatory compliance monitoring uses AI to track regulatory changes relevant to a specific industry or jurisdiction, alert legal and compliance teams to relevant developments, and assist with compliance documentation.
Where AI fails in legal contexts
Hallucinated citations are the most notorious legal AI failure. AI systems have generated plausible-looking but entirely fabricated case citations, which have in some documented instances been submitted in legal filings before the fabrication was discovered.
Jurisdictional errors occur when AI applies the law of one jurisdiction to a question that requires analysis under a different one. A contract governed by English law and one governed by New York law may look superficially similar but involve materially different legal rules. AI that fails to handle this distinction reliably is a liability risk.
Overconfident legal advice is a regulatory concern in jurisdictions where providing legal advice without qualification is restricted. AI that produces specific legal conclusions without appropriate hedging or referral to qualified legal advice may create regulatory exposure for the companies deploying it.
Failure to track recency is a recurring problem. AI trained on data with a specific cutoff may describe the law as it existed at training time rather than as it currently stands. In fast-moving regulatory areas, this can be materially misleading.
What legal AI evaluators do
Legal AI evaluators assess whether outputs correctly apply the relevant legal rules for the specified jurisdiction, accurately describe the current state of the law, and handle uncertainty appropriately. Evaluating citation accuracy, jurisdictional specificity, and the appropriate distinction between describing the law and giving legal advice are core tasks.
Practice area knowledge matters significantly. A general law graduate is well-positioned for general legal evaluation tasks. A specialist in commercial property, corporate finance, or employment law can evaluate AI outputs in those practice areas at a depth that general legal knowledge cannot reach.
AI in finance
What is being built
Investment research assistance is a major application. AI tools that summarise earnings reports, extract key metrics from financial filings, monitor analyst sentiment, and generate initial research notes are deployed at asset managers, hedge funds, and investment banks.
Risk analysis and monitoring uses AI to process large volumes of data for patterns that signal emerging risks: credit risk in loan portfolios, market risk in trading positions, operational risk in transaction data. These applications are often more quantitative and less language-model-based than legal or clinical AI.
Regulatory compliance and reporting is a growing AI application area. Generating and reviewing regulatory reports, monitoring communications for compliance issues, and flagging transactions for anti-money-laundering review are all areas where AI is being deployed.
Financial document processing, extracting structured data from unstructured financial documents, is a high-volume application with significant operational efficiency value for institutions that process large numbers of financial statements, prospectuses, or loan applications.
Where AI fails in financial contexts
Calculation errors in AI financial outputs can be subtle and expensive. An AI that extracts financial metrics from a filing but misapplies the accounting treatment for a specific item, or that generates an analysis that seems reasonable but uses an incorrect base figure, creates risk that compounds through downstream decisions.
Regulatory misstatement is a significant concern. Financial regulation varies by jurisdiction, product type, and counterparty type. AI that provides confident but jurisdiction-inappropriate or product-inappropriate regulatory guidance creates compliance exposure.
Overstating certainty about uncertain financial outcomes is a recurring problem. Financial markets involve genuine uncertainty. AI that presents probabilistic outcomes as more certain than they are, or that describes historical patterns as predictive without appropriate qualification, misrepresents what the analysis can actually support.
What financial AI evaluators do
Financial AI evaluators assess calculation accuracy, regulatory appropriateness, and the adequacy of uncertainty expression in AI financial outputs. Quantitative backgrounds that can assess whether a financial model's logic is sound, and professional experience with regulatory requirements in specific financial sectors, are both relevant.
The common thread
Across all three domains, the pattern is the same. AI is being deployed in contexts where errors have real consequences: clinical decisions, legal positions, financial outcomes. The systems being built need ongoing human expert evaluation to remain reliable as they encounter new task types, edge cases, and regulatory changes.
That ongoing evaluation requirement is structural. It does not diminish as the AI improves. It shifts. Better AI in these domains encounters more complex tasks, handles more varied cases, and is deployed in higher-stakes contexts. The expertise required of human evaluators scales with the sophistication of what is being evaluated.
For people with genuine professional or academic backgrounds in medicine, law, or finance, this is a market that rewards your specific knowledge directly and increasingly.
Frequently asked questions
Does AI deployment in professional services create legal liability for the companies deploying it? This is an evolving area. Current frameworks in most jurisdictions treat AI as a tool rather than an autonomous actor, meaning liability generally sits with the professional or organisation using the AI. This is one of the drivers of demand for robust AI evaluation: companies deploying AI in professional contexts need to demonstrate that their systems are reliable to manage their liability exposure.
Are there ethical concerns about AI replacing professional judgment in these domains? The dominant deployment model in all three domains is decision support rather than decision replacement. AI assists clinicians, lawyers, and financial professionals rather than acting autonomously. Human oversight is built into the deployment model, in part because regulatory frameworks require it and in part because the consequences of errors make full automation unacceptable in most professional contexts.
How quickly is AI capability changing in these domains? Rapidly. The capabilities of clinical, legal, and financial AI today are significantly greater than they were two years ago, and the trajectory of improvement is continuing. This means that the specific tasks where human evaluation is most needed shift over time, but the overall requirement for specialist human oversight does not diminish.
Summary
AI deployment in medicine, law, and finance is mature enough to be consequential and developing fast enough that reliable performance requires ongoing human expert evaluation. The failure modes in each domain are domain-specific and require specialist knowledge to detect. The demand for evaluators with clinical, legal, and financial backgrounds is growing with deployment and is likely to continue doing so as AI is integrated further into professional practice.